Under the Production Linked Incentive (PLI) scheme, Lyfius Pharma Private Limited (Lyfius Pharma) invested ₹2,500 crores in Penicillin-G (Pen-G) facility Commercial production to ramp up in FY25, enhancing domestic production of critical Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs) Lyfius Pharma
POST TAGS:
Atmanirbhar BharatDr Mansukh Mandaviyaglobal pharmaceuticalGovernment of India'shealth & family welfarehealthcareHon’ble Prime Minister Shri Narendra ModiKSMsLyfius Pharma’sMr. M.V. Rama KrishnaPharmapharmaceuticalShri Prataprao JadhavShri. Jagat Prakash NaddaSushri Shobha KarandlajeUnion Minister of Chemicals & FertilizersUnion Minister of Labour